journal article·2020-02-12

Exploration of the Natural Active Small-Molecule Drug-Loading Process and Highly Efficient Synergistic Antitumor Efficacy

Jiacheng Wang, Haitian Zhao, Kangkang Zhi, Xin Yang

Publisher page

Abstract

The development and application of nano-drug carriers might provide an excellent opportunity for cancer therapy. However, it is still an important challenge to realize the regulation and control of drug loading by analyzing the assembly process of carrier-loaded drugs. Herein, we show a "self-contained bioactive nanocarrier" system, which is prepared from ursolic acid, one of the very promising biologically active natural products with self-assembly properties. The study decrypts the assembly process of drug-carrier interaction and achieves the regulation of drug loading by controlling the interaction force. This nanocarrier highlights the unique advantages of active natural products in therapeutic efficacy and health benefits. In antitumor experiments, the carrier and drug demonstrated synergistic therapeutic efficacy. Furthermore, the nanocarrier is biosafe and capable of reducing the risk of liver damage induced by chemotherapeutics through the upregulation of key antioxidant pathways. Taken together, this "self-contained bioactive nanocarrier" system makes up for the drawback that conventional nanocarriers have no therapeutic efficacy and health benefits and eliminates the trouble of the toxic side effects associated with chemotherapy agents and the additional toxicity caused by long-term use of nanocarriers.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications · Dendrimers and Hyperbranched Polymers

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Chemistry and Chemical Engineering, Harbin Institute of Technology, No. 92 West Dazhi Street, Nan Gang District, Harbin, Heilongjiang 150001, P. R. China

Funding

National Natural Science Foundation of China

References (58)

Show source-provided references
1. 10.3109/1061186x.2015.105104910.3109/1061186x.2015.1051049 ↗
2. 10.1016/j.ijpharm.2017.05.01610.1016/j.ijpharm.2017.05.016 ↗
3. 10.1021/cr500131f10.1021/cr500131f ↗
4. 10.1016/j.jconrel.2015.03.02010.1016/j.jconrel.2015.03.020 ↗
5. 10.1016/j.ijpharm.2015.01.01710.1016/j.ijpharm.2015.01.017 ↗
6. 10.1016/j.jconrel.2016.03.01210.1016/j.jconrel.2016.03.012 ↗
7. 10.1016/j.jconrel.2004.03.01310.1016/j.jconrel.2004.03.013 ↗
8. 10.1016/j.nano.2017.05.00710.1016/j.nano.2017.05.007 ↗
9. 10.1016/j.actbio.2015.10.01710.1016/j.actbio.2015.10.017 ↗
10. 10.1016/j.jconrel.2012.03.02010.1016/j.jconrel.2012.03.020 ↗
11. 10.1021/acs.bioconjchem.5b0060710.1021/acs.bioconjchem.5b00607 ↗
12. 10.1038/natrevmats.2016.1410.1038/natrevmats.2016.14 ↗
13. 10.1080/10408398.2016.116036310.1080/10408398.2016.1160363 ↗
14. 10.1080/00498254.2016.120576210.1080/00498254.2016.1205762 ↗
15. 10.1016/j.foodchem.2016.10.02910.1016/j.foodchem.2016.10.029 ↗
16. 10.1097/cad.0b013e328330fd9010.1097/cad.0b013e328330fd90 ↗
17. 10.1021/acs.chemrev.6b0065410.1021/acs.chemrev.6b00654 ↗
18. 10.1016/j.actbio.2018.10.03110.1016/j.actbio.2018.10.031 ↗
19. 10.1007/s11101-014-9367-z10.1007/s11101-014-9367-z ↗
20. 10.1016/j.ejmech.2011.07.05710.1016/j.ejmech.2011.07.057 ↗
21. 10.3390/ijms1901026310.3390/ijms19010263 ↗
22. 10.1016/j.phrs.2009.01.01710.1016/j.phrs.2009.01.017 ↗
23. 10.1007/s11224-011-9881-110.1007/s11224-011-9881-1 ↗
24. 10.1039/c8nj01302k10.1039/c8nj01302k ↗
25. 10.1038/nnano.2014.20810.1038/nnano.2014.208 ↗
26. 10.1038/s41467-019-09601-310.1038/s41467-019-09601-3 ↗
27. 10.1021/acs.molpharmaceut.8b0044410.1021/acs.molpharmaceut.8b00444 ↗
28. 10.1039/c7nr08368h10.1039/c7nr08368h ↗
29. 10.1007/s12274-019-2470-010.1007/s12274-019-2470-0 ↗
30. 10.1002/adfm.20180296110.1002/adfm.201802961 ↗
31. 10.1016/j.addr.2010.10.00810.1016/j.addr.2010.10.008 ↗
32. 10.1016/j.biomaterials.2010.01.06510.1016/j.biomaterials.2010.01.065 ↗
33. 10.1016/j.biomaterials.2011.01.02110.1016/j.biomaterials.2011.01.021 ↗
34. 10.1021/jf102319y10.1021/jf102319y ↗
35. 10.1080/10408398.2016.120375510.1080/10408398.2016.1203755 ↗
36. 10.1038/nrc131710.1038/nrc1317 ↗
37. 10.1016/j.mpsur.2017.12.00210.1016/j.mpsur.2017.12.002 ↗
38. 10.1038/nrd450310.1038/nrd4503 ↗
39. 10.1002/adfm.20140158310.1002/adfm.201401583 ↗
40. 10.1016/j.colsurfb.2015.04.05710.1016/j.colsurfb.2015.04.057 ↗
41. 10.1038/s41565-017-0009-710.1038/s41565-017-0009-7 ↗
42. 10.1021/ja204413v10.1021/ja204413v ↗
43. 10.1038/s41563-017-0007-z10.1038/s41563-017-0007-z ↗
44. 10.1021/ar900233v10.1021/ar900233v ↗
45. 10.1039/c7ra02123b10.1039/c7ra02123b ↗
46. 10.1016/0168-3659(95)00077-110.1016/0168-3659(95)00077-1 ↗
47. Wang J. · J. Pharm. Sci. · 1999 · 88 · 1090
48. 10.1016/j.ijpharm.2008.07.01810.1016/j.ijpharm.2008.07.018 ↗
49. 10.1039/c9ra02801c10.1039/c9ra02801c ↗
50. 10.1073/pnas.110663410810.1073/pnas.1106634108 ↗
51. 10.4314/tjpr.v12i2.1910.4314/tjpr.v12i2.19 ↗
52. 10.1016/j.seppur.2006.04.00110.1016/j.seppur.2006.04.001 ↗
53. 10.1038/nnano.2016.16010.1038/nnano.2016.160 ↗
54. 10.1021/acs.molpharmaceut.8b0052710.1021/acs.molpharmaceut.8b00527 ↗
55. 10.1016/j.lfs.2016.01.01710.1016/j.lfs.2016.01.017 ↗
56. 10.1016/j.clinre.2014.09.00710.1016/j.clinre.2014.09.007 ↗
57. 10.1016/j.etap.2014.03.01110.1016/j.etap.2014.03.011 ↗
58. 10.1016/j.lfs.2005.05.06010.1016/j.lfs.2005.05.060 ↗